ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $329,526 | -48.3% | 29,501 | -0.9% | 0.00% | 0.0% |
| Q2 2023 | $636,779 | -48.7% | 29,756 | -3.0% | 0.00% | -50.0% |
| Q1 2023 | $1,240,901 | -16.6% | 30,685 | -4.1% | 0.00% | -33.3% |
| Q4 2022 | $1,487,896 | -10.4% | 31,984 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,660,000 | -18.3% | 32,002 | -25.6% | 0.00% | -25.0% |
| Q2 2022 | $2,033,000 | +6.9% | 43,003 | +61.0% | 0.00% | +33.3% |
| Q1 2022 | $1,901,000 | -11.5% | 26,710 | -7.1% | 0.00% | 0.0% |
| Q4 2021 | $2,149,000 | +40.6% | 28,736 | -32.0% | 0.00% | 0.0% |
| Q3 2015 | $1,528,000 | -17.5% | 42,278 | +2.6% | 0.00% | -25.0% |
| Q2 2015 | $1,853,000 | +138.5% | 41,191 | +62.2% | 0.00% | +100.0% |
| Q1 2015 | $777,000 | -41.9% | 25,393 | -3.4% | 0.00% | -33.3% |
| Q4 2014 | $1,337,000 | +27.8% | 26,284 | -0.5% | 0.00% | +50.0% |
| Q3 2014 | $1,046,000 | -6.4% | 26,427 | +1.8% | 0.00% | 0.0% |
| Q2 2014 | $1,118,000 | +7.8% | 25,961 | +0.1% | 0.00% | 0.0% |
| Q1 2014 | $1,037,000 | – | 25,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |